Clinical Trial Update: Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis [Phase 4]

View source ↗

Summary

Phase IV trial evaluating Jublia in mild to moderate toenail onychomycosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatophyte Infection of the Nail
• Toenail Onychomycosis

Drugs mentioned

• JUBLIA (efinaconazole)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Mild to Moderate Onychomycosis Due to Dermatophyte | Phase 4 | Status: COMPLETED